Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Ingria Pratama Capitalindo Tbk. (GRIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Ingria Pratama Capitalindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 6.8K 24h volume), while Ingria Pratama Capitalindo Tbk. trades at Rp148 (market cap 1.09T, 204.2K 24h volume). The key difference: Ingria Pratama Capitalindo Tbk. is far larger — about 3.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Ingria Pratama Capitalindo Tbk. is more actively traded (204.2K versus 6.8K). Which is the better fit depends on your goals.
| DGNS | GRIA | |
|---|---|---|
Market Cap | 319B | 1.09T |
Volume | 6.8K | 204.2K |
Lot | 68 | 2.04K |
Turnover | 1.56M | 30.17M |
Average Price | 229 | 147.76 |
Value | 1.56M | 30.17M |
Indicative Equilibrium Price | 232 | 148 |
Indicative Equilibrium Volume | 200 | 200 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Ingria Pratama Capitalindo Tbk.
PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.
Read more on GRIA →
